open access

Vol 5, No 4 (2020)
Original article
Published online: 2020-10-22
Get Citation

The functioning of patients on haemodialysis. Age as the main determinant of functional condition

Joanna Stanisławska1, Dorota Talarska2, Tomasz Niewiadomski3, Tomasz Ptaszyński4, Mary Kalfoss5, Magdalena Strugała6
·
Medical Research Journal 2020;5(4):231-237.
Affiliations
  1. Department of Preventive Medicine, University of Medical Sciences, Poznań, Poland
  2. Department of Preventive Medicine, University of Medical Sciences, Poznań, Poland
  3. Orthopedics - Rehabilitational Clinical Hospital, University of Medical Sciences, Poznań, Poland
  4. Institute of Psychology, Faculty of Social Sciences, Adam Mickiewicz University
  5. Diakonova University College, Oslo, Norway
  6. Department of Preventive Medicine, University of Medical Sciences, Poznań, Poland

open access

Vol 5, No 4 (2020)
ORIGINAL ARTICLES
Published online: 2020-10-22

Abstract

Introduction. Chronic kidney disease (CKD) is a progressive disease, and in spite of the progress of medicine, the care of specialized medical staff, and the patient’s efforts, many of them develop its end-stage. The use of renal replacement therapy, haemodialysis, has provided patients with an opportunity to prolong their life, but due to complications, it leads to the deterioration in the quality of life.

Aim.
To identify factors affecting the functioning of haemodialysis patients.

Materials and methods.
The study involved 98 patients on haemodialysis, 37 women and 61 men. The average age was 59.65 ± 15.51 years. The research tool was the Barthel Index, IADL and ESAS-R scale, i.e. a scale of experiencing symptoms that may be associated with haemodialysis.

Results.
The mean renal replacement therapy period was 42.76 ± 50.30 months. The most common cause of haemodialysis was chronic glomerulonephritis (21.43%), diabetic nephropathy (18.37%), polycystic kidney disease (12.24%) and hypertensive nephropathy (9.18%). In the study group, the average score on the Barthel Index scale was 90.10 ± 14.82, while the IADL score was 20.24 ± 4.72 points. Women showed a slightly higher ability in basic and complex daily living activities. People up to 60 years of age showed a slightly higher ability. According to the ESAS-R scale (7–10 points), fatigue and drowsiness were the most intense symptoms. People older than 60 years of age more often experienced pain (p = 0.048), malaise (p = 0.203), appetite disorders (p = 0.232), other problems (p = 0.042).

Conclusions.
In spite of their older age, the patients showed quite good motor skills. The differences between men and women in the assessment of the severity of somatic symptoms slightly disappear in the elderly. Women showed a slightly higher ability in both basic and complex daily living activities. Older people experience more haemodialysis-related symptoms.

Abstract

Introduction. Chronic kidney disease (CKD) is a progressive disease, and in spite of the progress of medicine, the care of specialized medical staff, and the patient’s efforts, many of them develop its end-stage. The use of renal replacement therapy, haemodialysis, has provided patients with an opportunity to prolong their life, but due to complications, it leads to the deterioration in the quality of life.

Aim.
To identify factors affecting the functioning of haemodialysis patients.

Materials and methods.
The study involved 98 patients on haemodialysis, 37 women and 61 men. The average age was 59.65 ± 15.51 years. The research tool was the Barthel Index, IADL and ESAS-R scale, i.e. a scale of experiencing symptoms that may be associated with haemodialysis.

Results.
The mean renal replacement therapy period was 42.76 ± 50.30 months. The most common cause of haemodialysis was chronic glomerulonephritis (21.43%), diabetic nephropathy (18.37%), polycystic kidney disease (12.24%) and hypertensive nephropathy (9.18%). In the study group, the average score on the Barthel Index scale was 90.10 ± 14.82, while the IADL score was 20.24 ± 4.72 points. Women showed a slightly higher ability in basic and complex daily living activities. People up to 60 years of age showed a slightly higher ability. According to the ESAS-R scale (7–10 points), fatigue and drowsiness were the most intense symptoms. People older than 60 years of age more often experienced pain (p = 0.048), malaise (p = 0.203), appetite disorders (p = 0.232), other problems (p = 0.042).

Conclusions.
In spite of their older age, the patients showed quite good motor skills. The differences between men and women in the assessment of the severity of somatic symptoms slightly disappear in the elderly. Women showed a slightly higher ability in both basic and complex daily living activities. Older people experience more haemodialysis-related symptoms.

Get Citation

Keywords

functional ability, haemodialysis

About this article
Title

The functioning of patients on haemodialysis. Age as the main determinant of functional condition

Journal

Medical Research Journal

Issue

Vol 5, No 4 (2020)

Article type

Original article

Pages

231-237

Published online

2020-10-22

Page views

556

Article views/downloads

583

DOI

10.5603/MRJ.a2020.0039

Bibliographic record

Medical Research Journal 2020;5(4):231-237.

Keywords

functional ability
haemodialysis

Authors

Joanna Stanisławska
Dorota Talarska
Tomasz Niewiadomski
Tomasz Ptaszyński
Mary Kalfoss
Magdalena Strugała

References (38)
  1. Wieliczko M, Kulicki P, Matuszkiewicz-Rowińska J. [Classification, epidemiology and etiology of chronic kidney disease]. Wiad Lek. 2014; 67(3): 393–396.
  2. Rutkowski B. Przewlekła choroba nerek – problem nie tylko medyczny, ale także socjoekonomiczny. Post N Med. 2009; 10: 817–822.
  3. Rutkowski B, Król E. Epidemiology of chronic kidney disease in central and eastern europe. Blood Purif. 2008; 26(4): 381–385.
  4. ESRD patients in 2013. A global perspective. http://www.vision-fmc.com/ files/pdf_2/ESRD_Patients_2013.pdf.
  5. Tonelli M, Riella M. Chronic kidney disease and the aging population. Nephrol Dial Transplant. 2014; 29(2): 221–224.
  6. Low J, Smith G, Burns A, et al. The impact of end-stage kidney disease (ESKD) on close persons: a literature review. NDT Plus. 2008; 1(2): 67–79.
  7. Jabłońska M, Lubas A, Niemczyk S. Quality of life in chronic kidney disease. Nefrol Dial Pol. 2016; 20: 205–211.
  8. Rutkowski B. Highlights of the epidemiology of renal replacement therapy in Central and Eastern Europe. Nephrol Dial Transplant. 2006; 21(1): 4–10.
  9. Pluta A, Felsmann A, Faleńczyk K. Some health problems in the dialysis patient population and the share of nurses insolving tchem. Medycyna Rodzinna. 2014; 3: 128–132.
  10. Saad MM, El Douaihy Y, Boumitri C, et al. Predictors of quality of life in patients with end-stage renal disease on hemodialysis. Int J Nephrol Renovasc Dis. 2015; 8: 119–123.
  11. Kurella Tamura M, Covinsky KE, Chertow GM, et al. Functional status of elderly adults before and after initiation of dialysis. N Engl J Med. 2009; 361(16): 1539–1547.
  12. Cruz MC, Andrade C, Urrutia M, et al. Quality of life in patients with chronic kidney disease. Clinics (Sao Paulo). 2011; 66(6): 991–995.
  13. Jassal SV, Karaboyas A, Comment LA, et al. Functional Dependence and Mortality in the International Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2016; 67(2): 283–292.
  14. Kapka-Skrzypczak L, Lipin B, Niedźwiecka J, et al. Subjective assessment of quality of life of dialysis patients by peritoneal dialysis and hemodialysis. Probl Hig Epidemiol. 2012; 93(4): 790–797.
  15. O'Lone E, Connors M, Masson P, et al. Cognition in People With End-Stage Kidney Disease Treated With Hemodialysis: A Systematic Review and Meta-analysis. Am J Kidney Dis. 2016; 67(6): 925–935.
  16. Stewart AL, Hays RD, Ware JE. Methods of validating MOS health Measures. In: Stewart AL, Ware JE. ed. Measuring functioning and well-being: the medical outcomes study approach. Duke University Press, Durham, NC 1992: 309–324.
  17. Saby A, Miller LS. Functional Assessment in End-Stage Renal Disease: Enhancing Quality of Life. Semin Dial. 2016; 29(2): 170–172.
  18. Basińska MA, Waraksa-Wiśniewska M, Andruszkiewicz A. Nastrój jako wyznacznik akceptacji choroby pacjentów dializowanych. Nefrol Dial Pol. 2014; 18: 27–31.
  19. Aghakhani N, Sharif Nia H, Samad Zadeh S, et al. Quality of life during hemodialysis and study dialysis treatment in patients referred to teaching hospitals in Urmia-Iran in 2007. Caspian J Intern Med. 2011; 2(1): 183–188.
  20. Boudreau JE, Dubé A. Quality of life in end stage renal disease: a concept analysis. CANNT J. 2014; 24(1): 12–20.
  21. Gentile S, Jouve E, Dussol B, et al. Development and validation of a French patient-based health-related quality of life instrument in kidney transplant: the ReTransQoL. Health Qual Life Outcomes. 2008; 6: 78.
  22. Kocka K, Grabowska K, Bartoszek A, et al. Impact of socio-demographical factors on qualityof life of patients treated with haemodialysis. Hygeia Public Health. 2016; 51(1): 82–86.
  23. Muszalik M, Kędziora-Kornatowska K. Quality of life for the chronically ill elderly. Gerontol Pol. 2016; 14(4): 185–189.
  24. Gętek M, Nowakowska-Zajdel E, Czech N, et al. Quality of life of patients on dialysis and after renal transplantation. Ann Acad Med Siles. 2010; 64(5-6): 23–30.
  25. Saffari M, Pakpour AH, Naderi MK, et al. Spiritual coping, religiosity and quality of life: a study on Muslim patients undergoing haemodialysis. Nephrology (Carlton). 2013; 18(4): 269–275.
  26. Oliveira AP, Schmidt DB, Amatneeks TM, et al. Quality of life in hemodialysis patients and the relationship with mortality, hospitalizations and poor treatment adherence. J Bras Nefrol. 2016; 38(4): 411–420.
  27. Md Yusop NB, Yoke Mun C, Shariff ZM, et al. Factors associated with quality of life among hemodialysis patients in Malaysia. PLoS One. 2013; 8(12): e84152.
  28. Feroze U, Noori N, Kovesdy C, et al. Quality-of-Life and Mortality in Hemodialysis Patients: Roles of Race and Nutritional Status. Clin J Am Soc Nephrol. 2011; 6(5): 1100–1111.
  29. Zyoud SH, Daraghmeh DN, Mezyed DO, et al. Factors affecting quality of life in patients on haemodialysis: a cross-sectional study from Palestine. BMC Nephrol. 2016; 17(1): 44.
  30. Hemati Z, Alidosti M, Sharifirad G, et al. The relationship between depression and quality of life among hemodialysis patients in Chaharmahal and Bakhtiari province in the year 2011. J Educ Health Promot. 2013; 2: 6.
  31. Drayer RA, Piraino B, Reynolds CF, et al. Characteristics of depression in hemodialysis patients: symptoms, quality of life and mortality risk. Gen Hosp Psychiatry. 2006; 28(4): 306–312.
  32. Merom D, Sinnreich R, Aboudi V, et al. Lifestyle physical activity among urban Palestinians and Israelis: a cross-sectional comparison in the Palestinian-Israeli Jerusalem risk factor study. BMC Public Health. 2012; 12: 90.
  33. Lopes GB, Matos CM, Leite EB, et al. Depression as a potential explanation for gender differences in health-related quality of life among patients on maintenance hemodialysis. Nephron Clin Pract. 2010; 115(1): c35–c40.
  34. Dudkowska D, Rumianowski B, Grochans E, et al. Comparison of the life quality of hemodialysis and peritoneal patients. Probl Hig Epidemiol. 2012; 93(3): 529–535.
  35. Kao TW, Lai MS, Tsai TJ, et al. Economic, social, and psychological factors associated with health-related quality of life of chronic hemodialysis patients in northern Taiwan: a multicenter study. Artif Organs. 2009; 33(1): 61–68.
  36. Weisbord SD, Fried LF, Mor MK, et al. Renal provider recognition of symptoms in patients on maintenance hemodialysis. Clin J Am Soc Nephrol. 2007; 2(5): 960–967.
  37. Palmer BF, Clegg DJ, Palmer BF, et al. Sexual dysfunction in men and women with chronic kidney disease and end-stage kidney disease. Adv Ren Replace Ther. 2003; 10(1): 48–60.
  38. Ersoy-Kart M, Guldii O. Vulnerability to stress, perceived social support, and coping styles among chronic hemodialysis. Dial Transplant. 2005.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl